Pfizer adds $2.5 billion to cost-cutting plan, pushing total savings past $10 billion

Pfizer announced on Tuesday an additional $2.5 billion of cost reductions across the company, extending its multi-year austerity program.

The new cuts bring the cumulative savings effort to more than $10 billion since the initiative was first disclosed, reflecting ongoing pressure to improve margins.

The company said the measures will be applied company‑wide, though details on specific actions or impact on staffing were not provided.